Drugs / Hib-MCC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01553279 Background | Mar 2012 → Sep 2013 | meningococcal infection, viral infectious disease | MCM Vaccines B.V. | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hib-MCC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01553279 ↗ |
| Modality | Vaccine | “Haemophilus type b and meningococcal Group C conjugate vaccine” NCT01553279 ↗ |
| Route | Intramuscular | “administered via 0.5 mL intramuscular injection” NCT01553279 ↗ |